Loading data for GRMLW — first visit, this takes a few seconds.
Greenland Mines Ltd (GRMLW)
NasdaqCM: GRMLW
· Real-Time Price · USD
0.15
+0.00 (0.00%)
At close: Aug 18, 2026, 8:00 PM
Greenland Mines Ltd (GRMLW) Stock Price, Analysis & Data
0.00% (1D)
No data available
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -22.29M |
| Beta | 2.56 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | 0.35 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 4,040 |
| Avg. Volume (20D) | |
| Open | 0.16 |
| Previous Close | 0.15 |
| Day's Range | 0.15 - 0.16 |
| 52-Week Range | 0.15 - 0.16 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About GRMLW
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention...
IPO Date n/a
Employees 5
Stock Exchange NasdaqCM
Ticker Symbol GRMLW
Website https://greenlandmines.com
Financial Performance
In undefined, Greenland Mines Ltd's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial Statements